Novelties and New Developments in Retina & Technology

My Session Status

When:

10:45 AM, Sunday 3 Jun 2018 (1 hour 35 minutes)

Breaks:

Lunch 12:15 PM to 01:30 PM (1 hour 15 minutes)

Where:

Metro Toronto Convention Centre (South Building) - Room 803

Theme:

Retina

LEARNING OBJECTIVES
After this session, participants will be able to:

Integrate the assessment of macular and retinal nonperfusion into the clinical evaluation of patients with diabetic retinopathy
Describe recent advances in the interpretation and analysis of OCT angiography
Assess the clinical utility of novel drug delivery vehicles for intravitreal pharmacotherapy

CANMEDS ROLES: Leader, Medical Expert

Usha Chakravarthy MD, PhD

Participant

Arif Samad

Moderator

Amin Kherani MD, FRCSC

Moderator

Sub Sessions

Introduction

10:45 AM - 10:50 AM | 5 minutes

Peripheral retinal ischemia and macular perfusion: a correlational study in diabetic retinopathy

10:50 AM - 11:05 AM | 15 minutes

Keynote Speaker

Usha Chakravarthy MD, PhD

Participant

Changing the paradigm of retinal treatment through drug delivery

11:05 AM - 11:15 AM | 10 minutes

Authors: Varun Chaudhary, Ben Muirhead, Heather Sheardown Author Disclosure Block: V. Chaudhary: Grant/research support; Novartis, Bayer, Allergan. Employment/honoraria/consulting fees; Novartis, Bayer. Membership on an advisory panel, standing committee or board of directors; Novartis, Bayer. B. Muirhead: None. H. Sheardown: None. Abstract Body: Purpose: To assess three novel drug delivery vehicles for therapeutic retinal injections....

Varun Chaudhary

Participant

What have we learned from the data mining of EMR systems in diabetic retinopathy and neovascular AMD

11:15 AM - 11:30 AM | 15 minutes

Keynote Speaker

Usha Chakravarthy MD, PhD

Participant

The diagnostic utility of multifocal electroretinography in detecting chloroquine and hydroxychloroquine retinal toxicity

11:30 AM - 11:40 AM | 10 minutes

Authors: Adrian C. Tsang, Sina Ahmadi, John Hamilton, Jennifer Gao, Gianni Virgili, Stuart Coupland, Chloe Gottlieb Author Disclosure Block: A.C. Tsang: None. S. Ahmadi: None. J. Hamilton: None. J. Gao: None. G. Virgili: None. S. Coupland: None. C. Gottlieb: None. Abstract Body: Purpose: To evaluate the diagnostic accuracy of the multifocal electroretinogram (mfERG) as a screening test for detecting hydroxychloroquine (HCQ) and chloroquin...

Adrian C. Tsang MD

Participant

Changes in aqueous cytokine levels following treatment with aflibercept in treatment naïve patients with diabetic macular edema

11:40 AM - 11:50 AM | 10 minutes

Author Block: Michael Y. Mak, Verena Juncal, Rajeev Muni Author Disclosure Block: M.Y. Mak: None. V. Juncal: None. R. Muni: Grant/research support; Research funding support, Bayer Inc., Research funding support, Novartis. Employment/honoraria/consulting fees; Speaking Honorarium, Bayer Inc., Speaking Honorarium, Novartis. Abstract Body: Purpose: To determine changes in aqueous cytokine levels in treatment- naive DME patients during intrav...

Michael Y. Mak MD

Participant

Macular buckle without vitrectomy for myopic macular schisis - A Canadian case series

11:50 AM - 12:00 PM | 10 minutes

Authors: Parampal Grewal, Steven Lapere, Rishi R. Gupta, Mark Greve Author Disclosure Block: P. Grewal: None. S. Lapere: None. R.R. Gupta: None. M. Greve: None. Abstract Body: Purpose: To determine the effectiveness of a macular buckle procedure without vitrectomy for myopic macular schisis. Study Design: Retrospective case series. Methods: All patients who underwent macular buckle surgery without ...

Parampal Grewal MD

Participant

Differences in metamorphopsia measurements and optical coherence tomography morphological changes following rhegmatogenous retinal detachment repair: Analysis of a randomized controlled trial comparing pneumatic retinopexy to pars plana vitrectomy